Esophageal cancer surgery: Standard and keyhole incisions show similar outcomes

New research has found no evidence of a difference between recovery time and complications when comparing standard and keyhole surgical incisions for the treatment of esophageal cancer (cancer of the gullet).

CMN-005 by CoImmune for Relapsed Chronic Lymphocytic Leukemia (CLL): Likelihood of Approval

CMN-005 is under clinical development by CoImmune and currently in Phase II for Relapsed Chronic Lymphocytic Leukemia (CLL).

September 10, 2024

Novo Nordisk calls IRA ‘unprecedented departure’ from US Constitution

Novo Nordisk requested last week that a New Jersey federal court strike down CMS guidance around Medicare price negotiations, arguing that no law has given

December 13, 2023

Formycon and Fresenius Kabi announce File Acceptance for FYB202, a biosimilar candidate to Stelara® (ustekinumab), by the U.S. Food and Drug Administration – Biotech Investments

EQS-News: Formycon AG / Key word(s): Regulatory Admission Formycon and Fresenius Kabi announce File Acceptance for FYB202, a biosimilar candidate to Stelara® (ustekinumab), by the

December 1, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.